RightAnswer Knowledge Solutions Search Results for 137281-23-3

RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.

---

RightAnswer Proprietary Data Sources:

---

All Other Data Sources:

---

ChemID External Links:

---

Other Government Links Searched via RegsKnowledge:

Example Content from MEDITEXT for 137281-23-3:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

1. WITH THERAPEUTIC USE
   1. Myelosuppression is the dose-limiting toxicity with pemetrexed therapy. Other commonly occurring adverse effects following therapeutic administration of pemetrexed include: gastrointestinal distress (nausea, vomiting, constipation, anorexia, stomatitis/pharyngitis), dyspnea, neuropathy, and rash/desquamation.

2. WITH POISONING/EXPOSURE
   1. Pemetrexed administration, in doses of 600 mg/m(2) or greater, have resulted in neutropenia, anemia, thrombocytopenia, nausea and vomiting, diarrhea, and rash. Other possible overdose effects may include infection (with or without fever) and mucositis.

© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.